CDSCO Panel grants AstraZeneca's Protocol Amendment Proposal for Sodium zirconium cyclosilicate Dr. Divya Colin31 Dec 2023 5:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the protocol...
AstraZeneca to buy Gracell Biotechnologies for USD 1.2 billion Ruchika Sharma27 Dec 2023 10:00 AM ISTCambridge: AstraZeneca has entered into a definitive agreement to acquire Gracell Biotechnologies Inc., a global clinical-stage biopharmaceutical...
AstraZeneca Wainua gets USFDA nod for adults with polyneuropathy of hereditary transthyretin-mediated amyloidosis Ruchika Sharma24 Dec 2023 2:45 PM ISTUS: AstraZeneca and Ionis' Wainua (eplontersen) has been approved in the US for the treatment of the polyneuropathy of hereditary...
AstraZeneca India, Roche Diagnostics India collaborate to improve diagnostic testing for breast cancer Ruchika Sharma17 Dec 2023 10:00 AM ISTBengaluru: AstraZeneca Pharma India Ltd. has signed a memorandum of understanding (MoU) with Roche Diagnostics India to improve diagnostics for breast...
COPD treatment: CDSCO nod to AstraZeneca India to market triple drug combination inhalation aerosol Ruchika Sharma15 Dec 2023 4:30 PM ISTBangalore: Biopharmaceutical company AstraZeneca India has announced that it has received Central Drugs Standard Control Organisation (CDSCO)...
AstraZeneca gets CDSCO panel Nod to study anti-cancer drug Volrustomig in women with cervical cancer Dr. Divya Colin14 Dec 2023 6:00 PM ISTNew Delhi: The drug major AstraZeneca has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
AstraZeneca to acquire vaccine developer Icosavax for up to USD 1.1 billion Ruchika Sharma12 Dec 2023 3:30 PM ISTCambridge: AstraZeneca has entered into a definitive agreement to acquire Icosavax, Inc., a US-based clinical-stage biopharmaceutical company...
AstraZeneca gets a CDSCO panel Nod To study Rilvegostomig Dr. Divya Colin11 Dec 2023 6:00 PM ISTNew Delhi: The drug major AstraZeneca has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
AstraZeneca gets CDSCO panel Nod To study antihypertensive drug Baxdrostat Dr. Divya Colin9 Dec 2023 9:34 PM ISTNew Delhi: The drug major AstraZeneca has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
AstraZeneca discontinues 2 Phase III evidence trials for Lokelma Ruchika Sharma4 Dec 2023 4:00 PM ISTThe decision to discontinue the trials is not due to safety concerns and the positive benefit-risk of Lokelma does not change in the approved...
AstraZeneca signs USD 247 million deal with Absci to design antibody for cancer: Report Ruchika Sharma4 Dec 2023 12:30 PM ISTUnited Kingdom: Anglo-Swedish drugmaker AstraZeneca has signed a deal worth up to $247 million with U.S. artificial intelligence (AI) biologics firm...
Turkey launches investigation into 19 pharma cos Ruchika Sharma1 Dec 2023 12:49 PM ISTAnkara: Turkey's competition authority said on Thursday it had launched an investigation into 19 pharmaceutical companies to determine whether they...
